Cargando…
Diseases, Emerging and Infectious
Emerging and infectious diseases have persisted as leading causes of global morbidity and mortality. Caused by pathogens including bacteria, viruses, parasites, or fungi, they are known to pose serious health threats to the world's population dating back to ancient Egypt. In the 14th Century al...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153343/ http://dx.doi.org/10.1016/B978-0-08-102295-5.10439-1 |
_version_ | 1783521633463435264 |
---|---|
author | Antabe, Roger Ziegler, Bianca Rosa |
author_facet | Antabe, Roger Ziegler, Bianca Rosa |
author_sort | Antabe, Roger |
collection | PubMed |
description | Emerging and infectious diseases have persisted as leading causes of global morbidity and mortality. Caused by pathogens including bacteria, viruses, parasites, or fungi, they are known to pose serious health threats to the world's population dating back to ancient Egypt. In the 14th Century alone, infectious diseases were responsible for decimating 20–45% of the world's population. The discovery of vaccines, coupled with improved sanitation, hygiene, and health care, witnessed the eradication of several infectious diseases, although some have resurfaced or are resurfacing since the latter part of the 20th Century. While geography partly define hotspots for emerging and infectious diseases, low socioeconomic development, poverty, and underfunded health care systems remain driving forces for the reoccurrence of these diseases among vulnerable populations who experience material deprivation. To eradicate infectious diseases, a global response will have to prioritize the allocation of resources by way of expertise and technology to areas that are most affected. Furthermore, an effective surveillance system, and a rigorous vaccine deployment regime targeting vulnerable persons and regions is desirable in mitigating the impacts of these diseases. |
format | Online Article Text |
id | pubmed-7153343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71533432020-04-13 Diseases, Emerging and Infectious Antabe, Roger Ziegler, Bianca Rosa International Encyclopedia of Human Geography Article Emerging and infectious diseases have persisted as leading causes of global morbidity and mortality. Caused by pathogens including bacteria, viruses, parasites, or fungi, they are known to pose serious health threats to the world's population dating back to ancient Egypt. In the 14th Century alone, infectious diseases were responsible for decimating 20–45% of the world's population. The discovery of vaccines, coupled with improved sanitation, hygiene, and health care, witnessed the eradication of several infectious diseases, although some have resurfaced or are resurfacing since the latter part of the 20th Century. While geography partly define hotspots for emerging and infectious diseases, low socioeconomic development, poverty, and underfunded health care systems remain driving forces for the reoccurrence of these diseases among vulnerable populations who experience material deprivation. To eradicate infectious diseases, a global response will have to prioritize the allocation of resources by way of expertise and technology to areas that are most affected. Furthermore, an effective surveillance system, and a rigorous vaccine deployment regime targeting vulnerable persons and regions is desirable in mitigating the impacts of these diseases. 2020 2019-12-04 /pmc/articles/PMC7153343/ http://dx.doi.org/10.1016/B978-0-08-102295-5.10439-1 Text en Copyright © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Antabe, Roger Ziegler, Bianca Rosa Diseases, Emerging and Infectious |
title | Diseases, Emerging and Infectious |
title_full | Diseases, Emerging and Infectious |
title_fullStr | Diseases, Emerging and Infectious |
title_full_unstemmed | Diseases, Emerging and Infectious |
title_short | Diseases, Emerging and Infectious |
title_sort | diseases, emerging and infectious |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153343/ http://dx.doi.org/10.1016/B978-0-08-102295-5.10439-1 |
work_keys_str_mv | AT antaberoger diseasesemergingandinfectious AT zieglerbiancarosa diseasesemergingandinfectious |